TSBX: Turnstone Biologics Corp. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 7.94
Enterprise Value ($M) -20.99
Book Value ($M) 43.64
Book Value / Share 1.89
Price / Book 0.18
NCAV ($M) 25.55
NCAV / Share 1.10
Price / NCAV 0.31

Profitability (mra)
Return on Invested Capital (ROIC) -1.58
Return on Assets (ROA) -0.75
Return on Equity (ROE) -0.89

Liquidity (mrq)
Quick Ratio 4.17
Current Ratio 4.17

Balance Sheet (mrq) ($M)
Current Assets 34.22
Assets 40.14
Liabilities 8.67
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -72.49
Net Income -70.84

Cash Flow Statement (mra) ($M)
Cash From Operations -67.44
Cash from Investing 78.56
Cash from Financing 0.01

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
05-31 13G/A Langer Timothy 4.30 -23.17
04-29 13G/A Fmr Llc 5.99 -45.56

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 5,543 18,502 29.96
2025-04-16 36,609 91,750 39.90
2025-04-15 16,650 60,053 27.73
2025-04-14 4,673 21,001 22.25

(click for more detail)

Similar Companies
TNXP – Tonix Pharmaceuticals Holding Corp. TPST – Tempest Therapeutics, Inc.
TRAW – Traws Pharma, Inc. TTNP – Titan Pharmaceuticals, Inc.
UNCY – Unicycive Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io